BioPharmX To Ring New York Stock Exchange Opening
Post# of 223
Posted On: 07/14/2015 12:38:31 AM
BioPharmX To Ring New York Stock Exchange Opening Bell To Celebrate Its Listing On NYSE MKT
MENLO PARK, Calif., July 13, 2015
BioPharmX Corporation (NYSE MKT: BPMX), is pleased to announce that the company's chief executive officer and its president are invited by the New York Stock Exchange (NYSE) to ring the NYSE Opening Bell on Wednesday, July 15, 2015 to celebrate its listing. Its stock was uplisted and commenced trading on June 25, 2015.
"BioPharmX is proud to ring the opening bell on behalf of our employees, investors and other supporters. We found that the NYSE MKT, the premier U.S. equities market for listing and trading early stage companies, is committed to providing a strong platform for growth," said Jim Pekarsky, chief executive officer of BioPharmX Corporation. "We look forward to the great exposure the NYSE MKT will give us to a larger group of investors while increasing awareness of our pipeline of products being developed to address significant, unmet medical needs."
Jim Pekarsky and BioPharmX President, Anja Krammer, will both be present for this important ceremony.
MENLO PARK, Calif., July 13, 2015
BioPharmX Corporation (NYSE MKT: BPMX), is pleased to announce that the company's chief executive officer and its president are invited by the New York Stock Exchange (NYSE) to ring the NYSE Opening Bell on Wednesday, July 15, 2015 to celebrate its listing. Its stock was uplisted and commenced trading on June 25, 2015.
"BioPharmX is proud to ring the opening bell on behalf of our employees, investors and other supporters. We found that the NYSE MKT, the premier U.S. equities market for listing and trading early stage companies, is committed to providing a strong platform for growth," said Jim Pekarsky, chief executive officer of BioPharmX Corporation. "We look forward to the great exposure the NYSE MKT will give us to a larger group of investors while increasing awareness of our pipeline of products being developed to address significant, unmet medical needs."
Jim Pekarsky and BioPharmX President, Anja Krammer, will both be present for this important ceremony.
(0)
(0)